• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Catalog Number VERSAUNK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Uterine Perforation (2121)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: fertil steril.2009; 91: 1273¿8.Doi: 10.1016/j.Fertnstert.2008.01.083.(b)(4).
 
Event Description
It was reported in a journal article with title: a randomized trial comparing monopolar electrodes using glycine 1.5% with two different types of bipolar electrodes (tcris, versapoint) using saline, in hysteroscopic surgery the objectives of this randomized study was to compare three types of equipment during hysteroscopic resection.This study consist of 200 premenopausal women with menorrhagia caused by dysfunctional bleedings, fibroids, or polyps.Of which, 64 patients were randomized under the monopolar group (age: 44.9 ± 5.1), 71 patients in the tcr group (age: 43.2 ± 5.0), and 65 patients in the gynecare versapoint (ethicon) group (age: 44.6 ± 5.0).In the gynecare versapoint group, reported complications included lack of sterilized equipment (n-1) which lead to exclusion after randomization, technical problems during the procedure (n-4) which led to change of equipment and exclusion after randomization , and perforation (n-1).In conclusion, the results suggest that hysteroscopic resection in saline has an improved safety profile compared with resection in glycine 1.5%, because of the absence of reduction in serum sodium after intravasation.Although the authors observed more fluid deficit in the two saline groups, the authors did not observe any side effects.The tcris appears to be as effective as the monopolar equipment, concerning operating time and tissue removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSAPOINT ELECTRODE UNKNOWN PRODUCT
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
ETHICON INC.
1210 ward avenue
west chester PA 19380
Manufacturer (Section G)
ETHICON INC.-GYRUS MEDICAL LTD
Manufacturer Contact
kara ditty-bovard
1210 ward avenue
west chester, PA 19380
6107428552
MDR Report Key9160327
MDR Text Key166951747
Report Number2210968-2019-88402
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeNO
PMA/PMN Number
K040302
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 09/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVERSAUNK
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/16/2019
Initial Date FDA Received10/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-